Associations of combined polymorphisms of the platelet membrane glycoproteins Ia and IIIa and the platelet-endothelial cell adhesion molecule-1 and P-Selectin genes with IVF implantation failures

J Obstet Gynaecol. 2017 Apr;37(3):363-369. doi: 10.1080/01443615.2016.1256978. Epub 2017 Feb 7.

Abstract

The aim of the study was to investigate the combined impact of the genetic heterogeneity of the glycoproteins Ia (GpIa) and IIIa (GpIIIa) and the platelet-endothelial cell adhesion molecule-1 (PECAM-1) and P-Selectin genes on IVF embryo transfer implantation failures (IVF-ET failures). Sixty nulligravida women with previous IVF-ET failures and 60 fertile controls were genotyped for the GpIa-C807T, GpIIIa-PlA1/PA2, PECAM-1-C373G (Leu125Val) and P-Selectin-A37674C (Thr715Pro) polymorphisms by pyrosequencing. Compared with wild-type combined homozygotes, carriers of combinations of risk alleles in two gene loci were at significantly increased risk for IVF-ET failure, whereas carriers of the combination of GpIa-807T, GpIIIa-PlA2 and PECAM-1-373G alleles had OR = 52.50 (95%CI: 4.05-680.95, p < .001). The area under the receiver-operating characteristic curve (AUC) based on the number of polymorphisms and the number of risk alleles per subject was 75.4% (95%CI: 66.7%-82.8%, p < .001) and 72.5% (95%CI: 63.6%-80.3%, p < .001), respectively. The OR per polymorphism and risk allele increase was 4.26 (95%CI: 2.15-8.41, p < .001) and 2.85 (95%CI: 1.71-4.76, p < .001), respectively. The above associations were more robust among younger women. The combined analysis of these polymorphisms revealed strong association of combined carriers with IVF-ET failures especially for younger women and provided a genetic risk score with good diagnostic accuracy in the prediction of IVF-ET failures.

Keywords: IVF; SNP; implantation; platelets; polymorphisms; thrombophilia.

MeSH terms

  • Adult
  • Age Factors
  • Area Under Curve
  • Biomarkers / blood
  • Case-Control Studies
  • Embryo Implantation / genetics*
  • Female
  • Fertilization in Vitro*
  • Heterozygote
  • Humans
  • Integrin alpha2 / blood
  • Integrin alpha2 / genetics*
  • Integrin beta3 / blood
  • Integrin beta3 / genetics*
  • P-Selectin / genetics*
  • Platelet Endothelial Cell Adhesion Molecule-1 / genetics*
  • Polymorphism, Single Nucleotide*
  • Risk
  • Sensitivity and Specificity
  • Treatment Failure

Substances

  • Biomarkers
  • Integrin alpha2
  • Integrin beta3
  • P-Selectin
  • Platelet Endothelial Cell Adhesion Molecule-1